Nonopioid vs opioid analgesics after impacted third-molar extractions- (https:linkinghub.elsevier.com/retrieve/pii/S0002817724006391) ...

Prytime Medical, The REBOA Company™ , proudly announces the first civilian use of its pREBOA-PRO™ catheter in the European Union, following the device's receipt of CE Mark approval.

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the U.S. Food and Drug Administration ...